Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents. 2013

Maria J Matos, and Saleta Vazquez-Rodriguez, and Lourdes Santana, and Eugenio Uriarte, and Cristina Fuentes-Edfuf, and Ysabel Santos, and Angeles Muñoz-Crego
Departamento de Química Orgánica, Facultad de Farmacia, Universidad de Santiago de Compostela, 15782 Santiago de Compostela, Spain. mariacmatos@gmail.com

A new series of amino/nitro-substituted 3-arylcoumarins were synthesized and their antibacterial activity against clinical isolates of Staphylococcus aureus (Gram-positive) and Escherichia coli (Gram-negative) was evaluated. Some of these molecules exhibited antibacterial activity against S. aureus comparable to the standards used (oxolinic acid and ampicillin). The preliminary structure-activity relationship (SAR) study showed that the antibacterial activity against S. aureus depends on the position of the 3-arylcoumarin substitution pattern. With the aim of finding the structural features for the antibacterial activity and selectivity, in the present manuscript different positions of nitro, methyl, methoxy, amino and bromo substituents on the 3-arylcoumarin scaffold were reported.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009574 Nitro Compounds Compounds having the nitro group, -NO2, attached to carbon. When attached to nitrogen they are nitramines and attached to oxygen they are NITRATES. Nitrated Compounds
D009675 Novobiocin An antibiotic compound derived from Streptomyces niveus. It has a chemical structure similar to coumarin. Novobiocin binds to DNA gyrase, and blocks adenosine triphosphatase (ATPase) activity. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p189) Crystallinic Acid,Streptonivicin,Novobiocin Calcium,Novobiocin Sodium,Novobiocin, Monosodium Salt,Calcium, Novobiocin,Monosodium Salt Novobiocin,Sodium, Novobiocin
D001728 Dicumarol An oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases. Bishydroxycoumarin,Dicoumarin,Dicoumarol
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000588 Amines A group of compounds derived from ammonia by substituting organic radicals for the hydrogens. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amine
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Maria J Matos, and Saleta Vazquez-Rodriguez, and Lourdes Santana, and Eugenio Uriarte, and Cristina Fuentes-Edfuf, and Ysabel Santos, and Angeles Muñoz-Crego
September 1984, Journal of medicinal chemistry,
Maria J Matos, and Saleta Vazquez-Rodriguez, and Lourdes Santana, and Eugenio Uriarte, and Cristina Fuentes-Edfuf, and Ysabel Santos, and Angeles Muñoz-Crego
November 1999, Journal of medicinal chemistry,
Maria J Matos, and Saleta Vazquez-Rodriguez, and Lourdes Santana, and Eugenio Uriarte, and Cristina Fuentes-Edfuf, and Ysabel Santos, and Angeles Muñoz-Crego
November 1985, Journal of medicinal chemistry,
Maria J Matos, and Saleta Vazquez-Rodriguez, and Lourdes Santana, and Eugenio Uriarte, and Cristina Fuentes-Edfuf, and Ysabel Santos, and Angeles Muñoz-Crego
April 1993, Journal of medicinal chemistry,
Maria J Matos, and Saleta Vazquez-Rodriguez, and Lourdes Santana, and Eugenio Uriarte, and Cristina Fuentes-Edfuf, and Ysabel Santos, and Angeles Muñoz-Crego
August 2009, Journal of medicinal chemistry,
Maria J Matos, and Saleta Vazquez-Rodriguez, and Lourdes Santana, and Eugenio Uriarte, and Cristina Fuentes-Edfuf, and Ysabel Santos, and Angeles Muñoz-Crego
March 1989, Journal of medicinal chemistry,
Maria J Matos, and Saleta Vazquez-Rodriguez, and Lourdes Santana, and Eugenio Uriarte, and Cristina Fuentes-Edfuf, and Ysabel Santos, and Angeles Muñoz-Crego
December 1995, Chemical & pharmaceutical bulletin,
Maria J Matos, and Saleta Vazquez-Rodriguez, and Lourdes Santana, and Eugenio Uriarte, and Cristina Fuentes-Edfuf, and Ysabel Santos, and Angeles Muñoz-Crego
May 1996, Chemical & pharmaceutical bulletin,
Maria J Matos, and Saleta Vazquez-Rodriguez, and Lourdes Santana, and Eugenio Uriarte, and Cristina Fuentes-Edfuf, and Ysabel Santos, and Angeles Muñoz-Crego
November 2012, European journal of medicinal chemistry,
Maria J Matos, and Saleta Vazquez-Rodriguez, and Lourdes Santana, and Eugenio Uriarte, and Cristina Fuentes-Edfuf, and Ysabel Santos, and Angeles Muñoz-Crego
July 1978, Journal of pharmaceutical sciences,
Copied contents to your clipboard!